PharVision Advisers’s Trinseo TSE Stock Holding History

PharVision Advisers’s Portfolio TSE Stock Details TSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-58,413	Closed	-$298K	–	514
2024 Q4	$298K	Buy	+58,413	New	+$288K	0.25%	157

Other funds holding TSE

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

BCM

Brightline Capital Management Miami, Florida $338M AUM 197.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's TSE Position: Q1 2025 in Review

PharVision Advisers sold out of Trinseo (TSE) in Q1 2025, closing a stake of 58,413 shares — an estimated $298K sold.

PharVision Advisers first reported a position in TSE in Q4 2024 and held it in 1 quarter. The position peaked at $298K in Q4 2024. 85 funds tracked by Wall St. Rank hold TSE as of Q1 2025.

PharVision Advisers reported no remaining Trinseo position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 58,413 Trinseo shares in Q1 2025, an estimated $298K.
PharVision Advisers first reported a position in Trinseo in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Trinseo position peaked at $298K in Q4 2024.
85 funds tracked by Wall St. Rank held Trinseo as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.